Xi-ling Jiang

发表

Modification of 5-methoxy-N, N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2016, Pharmacological reports : PR.

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

D. Mager, A. Yu, S. Schmidt, 2016, Acta pharmaceutica Sinica. B.

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2015, Neuropharmacology.

Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.

L. Peletier, L. Lesko, A. Shuldiner, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N , N-Dimethyltryptamine , and the Impact of CYP 2 D 6 Status

D. Mager, A. Yu, Xi-ling Jiang, 2013 .

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status

D. Mager, A. Yu, Xi-ling Jiang, 2013, Drug Metabolism and Disposition.

Pinoline May be Used as a Probe for CYP2D6 Activity

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Drug Metabolism and Disposition.

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Biochemical pharmacology.

Pinoline May Be Utilized as a Probe for CYP 2 D 6 Activity

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2008 .

Microsoft Word-23255875-file00

Xi-ling Jiang, Hong-Wu Shen, Ai‐Ming Yu, 2011 .

Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2009, Bioanalysis.

Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

Stephan Schmidt, Lawrence J Lesko, L. Lesko, 2015, Clinical Pharmacokinetics.

Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells.

Guang-Ji Wang, Hao Li, M. Roberts, 2005, Biological & pharmaceutical bulletin.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

J. C. Winter, A. Yu, Xi-ling Jiang, 2010, Current drug metabolism.

High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies.

I. Tucker, Guang-Ji Wang, Hao Li, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies.

Shuai Zhao, Guang-Ji Wang, Hao Li, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models

Ai-Ming Yu, F. Gonzalez, A. Yu, 2011, Drug metabolism reviews.

Humanized transgenic mouse models for drug metabolism and pharmacokinetic research.

F. Gonzalez, A. Yu, Xi-ling Jiang, 2011, Current drug metabolism.

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.

A. Yu, Xi-ling Jiang, Hong-Wu Shen, 2010, Biochemical pharmacology.

Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice

Hong-Wu Shen, Ai-Ming Yu, A. Yu, 2011, Drug Metabolism and Disposition.

Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs

Guang-Ji Wang, Hao Li, R. Sun, 2012, European Journal of Drug Metabolism and Pharmacokinetics.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

J. C. Winter, A. Yu, Xi-ling Jiang, 2010, Current drug metabolism.

Quantitation of Human Cytochrome P450 2D6 Protein with Immunoblot and Mass Spectrometry Analysis

A. Yu, Jin Cao, M. Felmlee, 2009, Drug Metabolism and Disposition.